1-5 of 5
Patrick Wen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of IDH305 in Patients with Advanced Malignancies Including Relapsed/Refractory AML and MDS That Harbor IDH1 R132 Mutations

Courtney D DiNardo, MD, Aaron D. Schimmer, MD PhD, Karen W.L. Yee, MD, Andreas Hochhaus, MD, Alwin Kraemer, MD, Richard D. Carvajal, MD, Filip Janku, MD PhD, Philippe Bedard, MD, Cecilia Carpio, MD, Antje Wick, MD, Gary K. Schwartz, MD, Patrick Schöffski, MD, Patrick Wen, MD, Martin J. van den Bent, MD, Mark Rosenthal, MD PhD, Jessica O'Keeffe, BS, Xueying Chen, PhD, Raymond Pagliarini, PhD, Virna Schuck, PhD, Andrea Myers, MD PhD, Andrew Wei
Journal: Blood
Blood (2016) 128 (22): 1073.
https://doi.org/10.1182/blood.V128.22.1073.1073
Published: 2016
Journal Articles

CNS Hodgkin lymphoma

Brief Report
Elizabeth R Gerstner, Lauren E Abrey, David Schiff, Andrés J. M Ferreri, Andrew Lister, Silvia Montoto, Richard Tsang, Eckhard Thiel, Francesc Graus, Dirk Behringer, Gerald Illerhaus, Susan Weaver, Patrick Wen, Alfredo Voloschin, Nancy Lee Harris, Tracy T Batchelor
Journal: Blood
Blood (2008) 112 (5): 1658–1661.
https://doi.org/10.1182/blood-2008-04-151563
Published: 2008
Journal Articles

A Novel Role for CpG Oligonucleotides in Tumor Immunotherapy: CpG-ODN Induce Targeted Chemokine-Induced Lymphocyte Migration to the Peripheral Tissues in Humans.

W. Nicholas Haining, Holger Kanzler, Jeffrey Davies, Linda Drury, Jeffrey Kutok, Thomas Brenn, Jill Angelosanto, John Evans, Kate Russell, Stephen Rivoli, Suzanne George, Thomas Morgan, Xiaochun Li, Robert Coffman, Patrick Wen, George Demetri, Lee Nadler
Journal: Blood
Blood (2007) 110 (11): 1791.
https://doi.org/10.1182/blood.V110.11.1791.1791
Published: 2007
Journal Articles

The Identification of Hypercoagulable Markers in Patients with Malignant Gliomas and Venous Thromboembolism.

Rachel P. Rosovsky, MD, Patrick Wen, MD, Santosh Kesari, MD, Elizabeth M. Van Cott, MD, David J. Kuter, MD
Journal: Blood
Blood (2006) 108 (11): 4097.
https://doi.org/10.1182/blood.V108.11.4097.4097
Published: 2006
Journal Articles

Phase II Trial of Single Agent Bortezomib (VELCADE®) in Patients with Previously Untreated Multiple Myeloma (MM).

Paul G. Richardson, Asher Chanan-Khan, Robert L. Schlossman, Nikhil C. Munshi, Patrick Wen, Hannah Briemberg, David Kuter, Anne-Louise Oaklander, Sagar Lonial, Hani Hassoun, Deborah Doss, Kathleen Colson, Mary McKenney, Karen Hande, Alexandra Koryzna, Barbara Stoklas, Laura Lunde, Svetlana Gorelik, Cliona McAlister, Andrea Freeman, Diane Warren, Denise Collins, Dixie Esseltine, Anthony Amato, Kenneth C. Anderson
Journal: Blood
Blood (2004) 104 (11): 336.
https://doi.org/10.1182/blood.V104.11.336.336
Published: 2004